Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 4:14 pm Purchase |
2025-03-31 | 13G | Surrozen, Inc. SRZN |
Stonepine Capital Management, LLC | 332,451 9.900% |
87,793 (+35.88%) |
Filing History |
| 2025-05-14 4:12 pm Purchase |
2025-03-31 | 13G | OptiNose, Inc. OPTN |
Stonepine Capital Management, LLC | 788,647 7.800% |
199,990 (+33.97%) |
Filing History |
| 2025-05-14 4:10 pm Sale |
2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
Stonepine Capital Management, LLC | 1,434,997 3.800% |
-481,669 (-25.13%) |
Filing History |
| 2025-05-14 4:07 pm Sale |
2025-03-31 | 13G | CalciMedica, Inc. CALC |
Stonepine Capital Management, LLC | 628,672 4.600% |
-113,029 (-15.24%) |
Filing History |
| 2025-05-14 4:04 pm Sale |
2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE |
Stonepine Capital Management, LLC | 239,416 4.300% |
-46,979 (-16.40%) |
Filing History |
| 2025-02-25 5:16 pm Purchase |
2025-02-13 | 13G | Edesa Biotech, Inc. EDSA |
Stonepine Capital Management, LLC | 693,551 9.900% |
693,551 (New Position) |
Filing History |
| 2025-02-13 12:38 pm Purchase |
2024-12-31 | 13G | OptiNose, Inc. OPTN |
Stonepine Capital Management, LLC | 588,657 5.900% |
588,657 (New Position) |
Filing History |
| 2025-02-13 12:32 pm Sale |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management, LLC | 2,203,333 4.800% |
-440,287 (-16.65%) |
Filing History |
| 2025-02-13 12:15 pm Sale |
2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Stonepine Capital Management, LLC | 286,395 5.100% |
-79,041 (-21.63%) |
Filing History |
| 2025-02-13 12:07 pm Sale |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
Stonepine Capital Management, LLC | 2,353,099 6.000% |
-478,740 (-16.91%) |
Filing History |
| 2024-12-23 8:08 pm Purchase |
2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO |
Stonepine Capital Management, LLC | 1,916,666 5.200% |
1,916,666 (New Position) |
Filing History |
| 2024-12-13 2:55 pm Purchase |
2024-12-06 | 13G | CalciMedica, Inc. CALC |
Stonepine Capital Management, LLC | 741,701 5.400% |
741,701 (New Position) |
Filing History |
| 2024-11-20 5:21 pm Purchase |
2024-11-13 | 13G | OptiNose, Inc. OPTN |
Stonepine Capital Management, LLC | 544,975 5.400% |
544,975 (New Position) |
Filing History |
| 2024-11-13 5:42 pm Purchase |
2024-09-30 | 13G | Surrozen, Inc. SRZN |
Stonepine Capital Management, LLC | 244,658 7.300% |
45,500 (+22.85%) |
Filing History |
| 2024-11-13 5:39 pm Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management, LLC | 2,643,620 6.400% |
-23,046 (-0.86%) |
Filing History |
| 2024-11-13 5:38 pm Sale |
2024-09-30 | 13G | Evolus, Inc. EOLS |
Stonepine Capital Management, LLC | 1,369,821 2.200% |
-3,963,183 (-74.31%) |
Filing History |
| 2024-11-13 5:36 pm Purchase |
2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 626,862 9.990% |
61,378 (+10.85%) |
Filing History |
| 2024-11-13 5:35 pm Unchanged |
2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX |
Stonepine Capital Management, LLC | 372,797 9.990% |
0 (Unchanged) |
Filing History |
| 2024-11-13 5:34 pm Purchase |
2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Stonepine Capital Management, LLC | 307,229 9.990% |
307,229 (New Position) |
Filing History |
| 2024-11-13 5:32 pm Sale |
2024-09-30 | 13G | CalciMedica, Inc. CALC |
Stonepine Capital Management, LLC | 0 0.000% |
-1,045,204 (Position Closed) |
Filing History |